Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis

Published:2023-04 Issue:4 Volume:48 Page:101555
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Khan Safi U.^ORCID,Lone Ahmad N.,Akbar Usman Ali,Arshad Hassaan B.,Arshad Adeel,Arora Shilpkumar,Kaluski Edo,Aoun Joe,Goel Sachin S.,Shah Alpesh R.,Kleiman Neal S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference24 articles.

1. Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial;Giustino;JACC Cardiovasc Interv,2020

2. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons;Arnold;Circ Cardiovasc Qual Outcomes,2012

3. Repeat revascularization is a faulty end point for clinical trials;Kazi;Circ Cardiovasc Qual Outcomes,2012

4. Limitations of repeat revascularization as an outcome measure: JACC Review Topic of the Week;Lamelas;J Am Coll Cardiol,2019

5. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials;Shaikh;Am Heart J,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP